Scott Akker

3.0k total citations
58 papers, 1.3k citations indexed

About

Scott Akker is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, Scott Akker has authored 58 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Endocrinology, Diabetes and Metabolism, 30 papers in Surgery and 12 papers in Epidemiology. Recurrent topics in Scott Akker's work include Adrenal and Paraganglionic Tumors (25 papers), Pituitary Gland Disorders and Treatments (24 papers) and Hormonal Regulation and Hypertension (15 papers). Scott Akker is often cited by papers focused on Adrenal and Paraganglionic Tumors (25 papers), Pituitary Gland Disorders and Treatments (24 papers) and Hormonal Regulation and Hypertension (15 papers). Scott Akker collaborates with scholars based in United Kingdom, Germany and United States. Scott Akker's co-authors include Ashley Grossman, Shern L. Chew, William M Drake, John P. Monson, Anju Sahdev, Helen L. Storr, Nicola Tufton, Maralyn Druce, Krystallenia Alexandraki and Gregory Kaltsas and has published in prestigious journals such as New England Journal of Medicine, The Journal of Clinical Endocrinology & Metabolism and The American Journal of Human Genetics.

In The Last Decade

Scott Akker

55 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott Akker United Kingdom 23 987 614 246 176 172 58 1.3k
Maria Adelaide A. Pereira Brazil 16 515 0.5× 638 1.0× 182 0.7× 153 0.9× 441 2.6× 36 1.0k
Laure Cazabat France 20 908 0.9× 704 1.1× 260 1.1× 237 1.3× 155 0.9× 31 1.4k
Marianne S. Elston New Zealand 18 505 0.5× 322 0.5× 146 0.6× 213 1.2× 121 0.7× 59 972
Alexandra Chrisoulidou Greece 18 670 0.7× 438 0.7× 140 0.6× 94 0.5× 164 1.0× 54 910
Eleonora Duregon Italy 22 489 0.5× 717 1.2× 116 0.5× 168 1.0× 538 3.1× 43 1.3k
Gianluca Occhi Italy 24 742 0.8× 432 0.7× 189 0.8× 309 1.8× 116 0.7× 49 1.4k
Leandro Kasuki Brazil 23 1.6k 1.6× 767 1.2× 389 1.6× 241 1.4× 72 0.4× 87 1.8k
Marica Arvigo Italy 22 695 0.7× 244 0.4× 402 1.6× 244 1.4× 70 0.4× 48 1.2k
A. Pia Italy 18 817 0.8× 750 1.2× 99 0.4× 130 0.7× 265 1.5× 26 1.1k
Jean‐Louis Kraimps France 21 811 0.8× 578 0.9× 385 1.6× 311 1.8× 79 0.5× 39 1.6k

Countries citing papers authored by Scott Akker

Since Specialization
Citations

This map shows the geographic impact of Scott Akker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Akker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Akker more than expected).

Fields of papers citing papers by Scott Akker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Akker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Akker. The network helps show where Scott Akker may publish in the future.

Co-authorship network of co-authors of Scott Akker

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Akker. A scholar is included among the top collaborators of Scott Akker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Akker. Scott Akker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Toole, Samuel, Catherine Hornby, Mark J. Hannon, et al.. (2021). Performance evaluation of scoring systems for predicting post‐operative hypertension cure in primary aldosteronism. Clinical Endocrinology. 95(4). 576–586. 5 indexed citations
2.
Akker, Scott, et al.. (2019). Glucocorticoid replacement therapies: past, present and future. Current Opinion in Endocrine and Metabolic Research. 8. 152–159. 1 indexed citations
3.
Daniel, Eleni, Miguel Debono, Stephen J. Walters, et al.. (2018). A prospective longitudinal study of Pasireotide in Nelson’s syndrome. Pituitary. 21(3). 247–255. 20 indexed citations
4.
Thomas, Julia, Filip Zemrak, Scott Akker, et al.. (2017). Renin-Angiotensin System Blockade Improves Cardiac Indices in Acromegaly Patients. Experimental and Clinical Endocrinology & Diabetes. 125(6). 365–367. 7 indexed citations
5.
Srirangalingam, Umasuthan, Prasad Patki, John Peters, et al.. (2016). Succinate Dehydrogenase B (SDHB)-Associated Bladder Paragangliomas. Clinical Genitourinary Cancer. 15(1). e131–e136. 6 indexed citations
6.
Srirangalingam, Umasuthan, et al.. (2016). Four generations of SDHB-related disease: complexities in management. Familial Cancer. 16(2). 279–282. 2 indexed citations
7.
Afshar, Farhad, Ian Sabin, Ghassan Alusi, et al.. (2016). Long-term outcomes of children treated for Cushing’s disease: a single center experience. Pituitary. 19(6). 612–624. 26 indexed citations
8.
Grossman, Ashley, Isabelle Goddard, P N Plowman, et al.. (2013). Sequelae and survivorship in patients treated with 131I-MIBG therapy. British Journal of Cancer. 109(3). 565–572. 22 indexed citations
9.
Alexandraki, Krystallenia, Gregory Kaltsas, Andrea M. Isidori, et al.. (2013). Long-term remission and recurrence rates in Cushing's disease: predictive factors in a single-centre study. European Journal of Endocrinology. 168(4). 639–648. 146 indexed citations
10.
Reznek, Rodney H., Matthew Matson, Anju Sahdev, et al.. (2011). A prospective evaluation of postural stimulation testing, computed tomography and adrenal vein sampling in the differential diagnosis of primary aldosteronism. Clinical Endocrinology. 76(2). 182–188. 43 indexed citations
11.
Chahal, Harvinder, Karen Stals, Martina Unterländer, et al.. (2011). AIPMutation in Pituitary Adenomas in the 18th Century and Today. New England Journal of Medicine. 364(1). 43–50. 94 indexed citations
12.
Barwick, Tara, Iain Murray, William M Drake, et al.. (2010). Single photon emission computed tomography (SPECT)/computed tomography using Iodine-123 in patients with differentiated thyroid cancer: additional value over whole body planar imaging and SPECT. European Journal of Endocrinology. 162(6). 1131–1139. 48 indexed citations
13.
Druce, Maralyn, Nishat Bharwani, Scott Akker, et al.. (2010). Intra-abdominal fibrosis in a recent cohort of patients with neuroendocrine ('carcinoid') tumours of the small bowel. QJM. 103(3). 177–185. 45 indexed citations
14.
Sabin, Ian, et al.. (2009). A “growing cause” of diabetic ketoacidosis: Figure 1. BMJ Case Reports. 2009. bcr1120081226–bcr1120081226. 8 indexed citations
15.
Walker, David, Louise Metherell, Scott Akker, et al.. (2009). d3‐GHR genotype does not explain heterogeneity in GH responsiveness in hypopituitary adults. Clinical Endocrinology. 72(6). 807–813. 16 indexed citations
16.
Alexandraki, Krystallenia, Gregory Kaltsas, Andrea M. Isidori, et al.. (2009). The prevalence and characteristic features of cyclicity and variability in Cushing's disease. European Journal of Endocrinology. 160(6). 1011–1018. 66 indexed citations
17.
Finney, Hazel, Scott Akker, Shern L. Chew, et al.. (2009). Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors. European Journal of Endocrinology. 161(1). 131–140. 32 indexed citations
18.
Evanson, Jane, David Walker, Scott Akker, et al.. (2007). Safety of GH replacement in hypopituitary patients with nonirradiated pituitary and peripituitary tumours. Clinical Endocrinology. 68(6). 965–969. 18 indexed citations
19.
Metherell, Louise, Scott Akker, Patricia B. Munroe, et al.. (2001). Pseudoexon Activation as a Novel Mechanism for Disease Resulting in Atypical Growth-Hormone Insensitivity. The American Journal of Human Genetics. 69(3). 641–646. 94 indexed citations
20.
Jenkins, Paul J., Scott Akker, S. L. Chew, et al.. (2000). Optimal dosage interval for depot somatostatin analogue therapy in acromegaly requires individual titration. Clinical Endocrinology. 53(6). 719–724. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Adelaide A. Pereira Breakdown of academic impact, for papers by Laure Cazabat Breakdown of academic impact, for papers by Marianne S. Elston Breakdown of academic impact, for papers by Alexandra Chrisoulidou Breakdown of academic impact, for papers by Eleonora Duregon Breakdown of academic impact, for papers by Gianluca Occhi Breakdown of academic impact, for papers by Leandro Kasuki Breakdown of academic impact, for papers by Marica Arvigo Breakdown of academic impact, for papers by A. Pia Breakdown of academic impact, for papers by Jean‐Louis Kraimps
Rankless by CCL
2026